Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Oct 15, 2019
Date Accepted: Jun 16, 2020
Date Submitted to PubMed: Jul 14, 2020

The final, peer-reviewed published version of this preprint can be found here:

Effects of a Novel Contextual Just-In-Time Mobile App Intervention (LowSalt4Life) on Sodium Intake in Adults With Hypertension: Pilot Randomized Controlled Trial

Dorsch M, Cornellier ML, Poggi AD, Bilgen F, Chen P, Wu C, An LC, Hummel SL

Effects of a Novel Contextual Just-In-Time Mobile App Intervention (LowSalt4Life) on Sodium Intake in Adults With Hypertension: Pilot Randomized Controlled Trial

JMIR Mhealth Uhealth 2020;8(8):e16696

DOI: 10.2196/16696

PMID: 32663139

PMCID: 7445610

The effects of a novel contextual just-in-time mobile application intervention on sodium intake in adults with hypertension: Results from the LowSalt4Life pilot study

  • Michael Dorsch; 
  • Maria L. Cornellier; 
  • Armella D. Poggi; 
  • Feriha Bilgen; 
  • Peiyu Chen; 
  • Cindy Wu; 
  • Lawrence C. An; 
  • Scott L. Hummel

ABSTRACT

Background:

High dietary sodium intake is a significant public health problem in the U.S.

Objective:

We created and studied a just-in-time mobile application intervention intended to reduce sodium intake.

Methods:

In a single center prospective open-label pilot study, 50 patients aged ≥18 years with treated hypertension were randomized (1:1, stratified by gender) to the mobile application (LowSalt4Life) or usual care for 8 weeks. The primary endpoint is the change in 24-hour urinary sodium excretion estimated from spot urine by the Kawasaki equation, analyzed using unpaired t-testing. Secondary outcomes include the change in sodium intake, confidence in following a low sodium diet, and blood pressure (BP).

Results:

From baseline to week 8, the change in Kawasaki estimated 24-hour urinary sodium excretion was -462±1220 mg in the App compared to 381±1460 mg in the No App group (p=0.03). The 24-hour urinary sodium excretion was -637±1524 mg in the App compared to -322±1485mg in the No App group (p=0.47). The estimated sodium intake per 24-hour recall was -1537±2693 vs. -233±2150 mg (p=0.07) and by Food Frequency Questionnaire was -1553±1764 vs. -515±1081 mg (p=0.01) in the App group compared to No App group. Systolic BP decreased from baseline in the App compared to No App group (-7.5 vs. -0.7 mmHg, p=0.12), but self-confidence did not change.

Conclusions:

In a randomized pilot study, the LowSalt4Life mobile application showed promise in reducing dietary sodium intake. A larger clinical trial is warranted to elucidate the effects of this intervention on blood pressure control. Clinical Trial: ClinicalTrials.gov NCT03099343 (https://clinicaltrials.gov/ct2/show/NCT03099343)


 Citation

Please cite as:

Dorsch M, Cornellier ML, Poggi AD, Bilgen F, Chen P, Wu C, An LC, Hummel SL

Effects of a Novel Contextual Just-In-Time Mobile App Intervention (LowSalt4Life) on Sodium Intake in Adults With Hypertension: Pilot Randomized Controlled Trial

JMIR Mhealth Uhealth 2020;8(8):e16696

DOI: 10.2196/16696

PMID: 32663139

PMCID: 7445610

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.